Mitochondrial damage is associated with an early immune response in inclusion body myositis
Brain · 03.09.2025 · 148 (9) · 3199-3214
DOI: 10.1093/brain/awaf118 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, online erschienen am 07.04.2025. Verfasst von Felix Kleefeld und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Berlin Institute of Health (BIH), Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt…. Hauptthemen laut MEDLINE: Myositis, Inclusion Body, Mitochondria. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Deutsche Gesellschaft für Muskelkranke, ERDF, Wellcome Discovery Award.
Abstract (Originalsprache)
Polymyositis with mitochondrial pathology (PM-Mito) was first identified in 1997 as a subtype of idiopathic inflammatory myopathy. Recent findings demonstrated significant molecular similarities between PM-Mito and inclusion body myositis (IBM), suggesting a trajectory from early to late IBM and prompting the inclusion of PM-Mito as an IBM precursor (early IBM) within the IBM spectrum. Both PM-Mito and IBM show mitochondrial abnormalities, suggesting that mitochondrial disturbance is a crucial element of IBM pathogenesis. The primary objective of this cross-sectional study was to characterize the mitochondrial phenotype in PM-Mito at histological, ultrastructural and molecular levels and to study the interplay between mitochondrial dysfunction and inflammation. Skeletal muscle biopsies of 27 patients with PM-Mito and 27 with typical IBM were included for morphological and ultrastructural analysis. Mitochondrial DNA (mtDNA) copy number and deletions were assessed by quantitative PCR and long-range PCR, respectively. In addition, full-length single-molecule sequencing of the mtDNA enabled precise mapping of deletions. Protein and RNA levels were studied using unbiased proteomic profiling, immunoblotting and bulk RNA sequencing. Cell-free mtDNA was measured in the serum of IBM patients. We found widespread mitochondrial abnormalities in both PM-Mito and IBM, illustrated by elevated numbers of cytochrome c oxidase (COX)-negative and succinate dehydrogenase (SDH)-positive fibres and prominent ultrastructural abnormalities, with disorganized and concentric cristae within enlarged and dysmorphic mitochondria. mtDNA copy numbers were significantly reduced, and multiple large-scale mtDNA deletions were already evident in PM-Mito compared with healthy age-matched controls, similar to the IBM group. The canonical cyclic GMP–AMP synthase/stimulator of interferon genes inflammatory pathway was activated in PM-Mito and IBM, and we detected elevated levels of circulating cell-free mtDNA indicative of mtDNA leakage. In PM-Mito and IBM, these findings were accompanied by dysregulation of proteins and transcripts linked to the mitochondrial membranes. In summary, we identified that mitochondrial dysfunction with multiple mtDNA deletions and depletion, disturbed mitochondrial ultrastructure and defects of the inner mitochondrial membrane are features of PM-Mito and IBM, underlining the concept of an IBM-spectrum disease. Notably, mitochondrial abnormalities precede tissue remodelling and infiltration by specific T-cell subpopulations (e.g. KLRG1+) characteristic of late IBM. The activation of inflammatory, DNA-sensing pathways might be related to mtDNA release, which would indicate a significant role of mitochondria-associated inflammation in the pathogenesis of IBM-spectrum disease. This study highlights the crucial role of early mitochondrial abnormalities in the pathomechanism of IBM, which might lead to new approaches to therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Berlin Institute of Health (BIH), Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt, Universität zu Berlin, 10117 Berlin, Germany.
- Department of Neurology, Heimer Institute for Muscle Research, University Hospital Bergmannsheil, Ruhr-University Bochum, 44789 Bochum, Germany.
- Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0QQ, UK.
- Department of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany.
- Department of Neurology, Friedrich-Baur-Institute, Ludwig-Maximilians-University, 80336 Munich, Germany.
- Leibniz-Institut für Analytische Wissenschaften-ISAS e.V., 44139 Dortmund, Germany.
ORCID-Profile: Felix Kleefeld, Anne Schänzer, Rita Horvath
Förderung
- Deutsche Gesellschaft für Muskelkranke
- ERDF
- Wellcome Discovery Award
- Medical Research Council
- Addenbrookes Charitable Trust
- Evelyn Trust
- Stoneygate Trust
- Lily Foundation
Zitieren
APA
Kleefeld, F., Cross, E., Lagos, D., Walli, S., Schoser, B., Hentschel, A., Ruck, T., Nelke, C., Hahn, K., Hathazi, D., Mammen, A. L., Casal-Dominguez, M., Gut, M., Gut, I. G., Heath, S., Schänzer, A., Goebel, H. H., Pinal-Fernandez, I., Roos, A., …, & Horvath, R. (2025). Mitochondrial damage is associated with an early immune response in inclusion body myositis. Brain, 148(9), 3199-3214. https://doi.org/10.1093/brain/awaf118
Vancouver
Kleefeld F, Cross E, Lagos D, Walli S, Schoser B, Hentschel A, et al. Mitochondrial damage is associated with an early immune response in inclusion body myositis. Brain. 2025;148(9):3199-3214. doi:10.1093/brain/awaf118
BibTeX
@article{Kleefeld2025,
author = {Kleefeld, Felix and Cross, Emily and Lagos, Daniel and Walli, Sara and Schoser, Benedikt and Hentschel, Andreas and Ruck, Tobias and Nelke, Christopher and Hahn, Katrin and Hathazi, Denisa and Mammen, Andrew L and Casal-Dominguez, Maria and Gut, Marta and Gut, Ivo Glynne and Heath, Simon and Schänzer, Anne and Goebel, Hans-Hilmar and Pinal-Fernandez, Iago and Roos, Andreas and Preuße, Corinna and Stenzel, Werner and Horvath, Rita},
title = {Mitochondrial damage is associated with an early immune response in inclusion body myositis},
journal = {Brain},
year = {2025},
volume = {148},
number = {9},
pages = {3199--3214},
doi = {10.1093/brain/awaf118}
}
EUVIMED